Stephanotic acid



Compound IDCDAMM02248
Common nameStephanotic acid
IUPAC name12-butan-2-yl-8,11,14-trioxo-15-[(5-oxopyrrolidine-2-carbonyl)amino]-9,16-di(propan-2-yl)-2,7,10,13-tetrazatricyclo[15.3.1.04,20]henicosa-1(20),3,17(21),18-tetraene-6-carboxylic acid
Molecular formulaC33H46N6O7

Experimental data

Retention time12.73
Adduct[M+H]+
Actual mz639.35
Theoretical mz639.35
Error1.06
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.3759

Identifiers and class information

Inchi keyUZOLEYGIZGZREX-NISZBAHGNA-N
SmilesO=C(O)C1NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CC2)C(C=3C=CC4=C(C3)NC=C4C1)C(C)C)C(C)CC)C(C)C
SuperclassOrganic acids and derivatives
ClassCarboxylic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)5
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)638.762
Computed dipole moment(dipole)13.109
Total solvent accessible surface area (SASA)811.344
Hydrophobic component of SASA (FOSA)471.816
Hydrophilic component of SASA (FISA)263.459
Pie component of the SASA (PISA)76.069
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1746.93
Number of hydrogen bond donors (donorHB)3.25
Number of hydrogen bond acceptors (accptHB)10.75
Free energy of solvation of dipole (dip^2/V)0.0983769
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0238861
Globularity descriptor (glob)0.86459
Predicted polarizability in cubic angstroms (QPpolrz)53.569
Predicted hexadecane/gas partition coefficient (QPlogPC16)17.087
Predicted octanol/gas partition coefficient (QPlogPoct)30.224
Predicted water/gas partition coefficient (QPlogPw)23.822
Predicted octanol/water partition coefficient (QPlogPo/w)1.195
Predicted aqueous solubility (QPlogS)-0.592
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.167
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)4.594
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.034
Predicted brain/blood partition coefficient (QPlogBB)-2.811
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3.39
Predicted skin permeability, log Kp (QPlogKp)-4.475
PM3 calculated ionization potential (IP(ev))8.941
PM3 calculated electron affinity (EA(eV))0.722
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-1.242
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)111.381
Van der Waals surface area (PSA)219.687
Number of nitrogen and oxygen atoms (#NandO)13
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P12821ACEAngiotensin-converting enzymeT98311SwissTargetPrediction
P35270SPRSubstance-P receptorT47094SwissTargetPrediction
P25101EDNRAEndothelin receptor ET-AT23499SwissTargetPrediction
P32239CCKBRCholecystokinin B receptor (by homology)T05849SwissTargetPrediction
P30989NTSR1Neurotensin receptor 1T02728SwissTargetPrediction
P24530EDNRBEndothelin receptor ET-BT92828SwissTargetPrediction
Q96DB2HDAC11Histone deacetylase 11T97903SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T98311DI0175Heart failure[ICD-11: BD10-BD1Z]P12821ACE
T98311DI0190Hypertension[ICD-11: BA00-BA04]P12821ACE
T47094DI0117Depression[ICD-11: 6A70-6A7Z]P35270SPR
T47094DI0293Nausea/vomiting[ICD-11: MD90]P35270SPR
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T05849DI0122Diagnostic imaging[ICD-11: N.A.]P32239CCKBR
T05849DI0327Pancreatic internal secretion disorder[ICD-11: 5A4Y]P32239CCKBR
T02728DI0207Indeterminate colitis[ICD-11: DD72]P30989NTSR1
T92828DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P24530EDNRB
T92828DI0356Pulmonary hypertension[ICD-11: BB01]P24530EDNRB

Copyright © 2025